| Diabetes Management and Research | Lifetime | 35 | US 20 | 99.77 |
| Diabetes Treatment and Management | Lifetime | 57 | US 29 | 99.71 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 49 | US 26 | 99.75 |
| Peripheral Artery Disease Management | Lifetime | 88 | US 61 | 99.15 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 47 | US 22 | 99.04 |
| Cardiovascular Function and Risk Factors | Lifetime | 383 | US 215 | 99.29 |
| Chronic Kidney Disease and Diabetes | Lifetime | 114 | US 54 | 99.19 |
| Metabolism, Diabetes, and Cancer | Lifetime | 230 | US 101 | 98.99 |
| Diabetic Foot Ulcer Assessment and Management | Lifetime | 178 | US 75 | 98.09 |
| Diabetes Management and Education | Lifetime | 179 | US 99 | 97.92 |
| Dialysis and Renal Disease Management | Lifetime | 413 | US 168 | 98.11 |
| Diabetes and associated disorders | Lifetime | 616 | US 238 | 97.73 |
| Cardiovascular Health and Disease Prevention | Lifetime | 555 | US 224 | 97.53 |
| Cardiovascular Health and Risk Factors | Lifetime | 222 | US 132 | 97.00 |
| Blood Pressure and Hypertension Studies | Lifetime | 924 | US 380 | 97.56 |
| Advanced Glycation End Products research | Lifetime | 490 | US 131 | 94.49 |
| Diabetes Management and Research | 2021-2025 | 13 | US 9 | 99.69 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 19 | US 7 | 99.34 |
| Diabetes Treatment and Management | 2021-2025 | 58 | US 33 | 99.40 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 13 | US 10 | 98.02 |
| Diabetes and associated disorders | 2021-2025 | 71 | US 41 | 97.86 |
| Pancreatic function and diabetes | 2021-2025 | 92 | US 51 | 97.90 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 71 | US 30 | 97.58 |
| Diabetes Management and Education | 2021-2025 | 126 | US 46 | 93.69 |
| Heart Failure Treatment and Management | 2021-2025 | 381 | US 133 | 95.34 |
| Diabetic Foot Ulcer Assessment and Management | 2021-2025 | 189 | US 50 | 92.90 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 949 | US 303 | 94.22 |
| Peripheral Artery Disease Management | 2021-2025 | 506 | US 219 | 89.33 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 917 | US 244 | 83.35 |
| Clinical practice guidelines implementation | 2021-2025 | 489 | US 92 | 76.62 |
